A new pill to lower blood sugar for people with type 2 diabetes was approved by the U.S. Food and Drug Administration on Friday. The drug, Rybelsus (semaglutide) is the first pill in a class of drugs called glucagon-like peptide (GLP-1) approved for use in the United States.
干细胞疗法
肝脏干细胞疗法
失代偿期肝硬化患者大多不得不选择肝移植, 但捐献器官的供应有限且成本高昂导致等待名单上的死亡率很高 . 自己身体的干细胞有帮助 阅读更多…